SEC Form 4 · accession 0001179110-15-013896
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc R Schneebaum
Officer — SVP and CFO
Period of report
Oct 2, 2015
Accepted (ET)
Oct 6, 2015 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.76 | Oct 2, 2015 | A | 153,100 | A | — | Oct 2, 2025 | Common Stock | 153,100 | 153,100 | D |
Explanation of responses
- F1The option vests as to 25% of the shares on October 2, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.